IONS ▼ -2.4% - Ionis Pharmaceuticals, Inc.
$IONS Ionis partner Roche announces new Phase 3 data showing sefaxersen significantly reduced proteinuria in people with IgA nephropathy (IgAN)
23-OCT-2026 01:39 PM ET
Share this post
More filings for $IONS
IONS ▲ +1.6% - Ionis Pharmaceuticals, Inc.Oct 22, 2026IONS ▼ -1.3% - Ionis Pharmaceuticals, Inc.Oct 16, 2026IONS ▲ +3.6% - Ionis Pharmaceuticals, Inc.Sep 23, 2026IONS ▲ +3.7% - Ionis Pharmaceuticals, Inc.Sep 22, 2026IONS ▲ +3.3% - Ionis Pharmaceuticals, Inc.Sep 22, 2026IONS ▼ -6.3% - Ionis Pharmaceuticals, Inc.Sep 4, 2026
View full $IONS filing history →💬 Comments
Loading comments…
Leave a comment